Luteolin: Antihistamine, Memory, and Brain Fog

Luteolin is a flavonoid found in fruits, vegetables, and herbs. It possesses a variety of anti-inflammatory, antihistamine, and antibacterial properties, according to research studies. Furthermore, it is neuroprotective, bringing benefits to the brain for memory, brain fog, and possibly protecting against neurodegenerative diseases.

In this article, I dive into the research studies on luteolin, explaining the clinical trials and examining the animal research on how it works. I’ll also explain how it is absorbed and how it interacts with genetic variants, such as COMT.

Luteolin: Where to get it and what research studies show

Luteolin is a flavonoid found in small amounts in several herbs and vegetables. Plants produce flavonoids, such as luteolin, as a cellular defense against pathogens or UV radiation. Many of these plant molecules also bring health benefits to us when we consume them.[ref]

Luteolin foods:  Parsley, carrots, artichokes, celery, thyme, chamomile tea, olive oil, oranges, and oregano contain the flavone luteolin.

Luteolin vs. lutein: Luteolin is not to be confused with lutein, a plant pigment that can help with macular degeneration.

Luteolin as an antihistamine and mast cell stabilizer:

Research shows that luteolin can act as a mast cell stabilizer and reduce histamine release.[ref][ref] This may benefit anyone dealing with mast cell activation syndrome (MCAS) or histamine intolerance.

Brain Fog in MCAS: The ‘brain fog’ term applies to the inability to think clearly or concentrate. According to some researchers, inflammation and histamine release cause brain fog. They believe that luteolin can help with brain fog, citing studies that show it can improve focus in children with autism.[ref].

Related article: Brain Fog and Genetics

Neuroprotective effects of luteolin:

Research shows that luteolin may have clinically meaningful neuroprotective effects. This is important since a lot of research studies only show very minor benefits that aren’t really meaningful.

Brain fog: Studies show that luteolin may help with cognitive dysfunction caused by inflammation. Luteolin decreases the cytokines that cause inflammation in the brain.[ref] Other research explains that luteolin may help specifically with “brain fog” by decreasing neuroinflammation.[ref]

Long Covid: Some researchers think that luteolin may help with brain fog, or cognitive issues, in long Covid.[ref] The mechanism of how luteolin could help seems logical, but there aren’t any clinical trials on luteolin for Long Covid (yet).

Neurodegenerative diseases such as Alzheimer’s: The creation of amyloid-beta, which builds up in plaques in Alzheimer’s sufferers’ brains, requires the O-glycosylation of the amyloid precursor protein. Inhibiting this process could reduce amyloid in the brain, at least in theory. Let me be clear: this is purely theoretical and has not been confirmed in human investigations.

  • Luteolin selectively inhibits the type of O-glycosylation (Mucin-type O-glycosylation) involved in the formation of amyloid-β.[ref]
  • Animal studies show luteolin inhibits neuroinflammation by controlling microglia activation.[ref]
  • In a mouse study of Alzheimer’s, luteolin protects against amyloid β memory dysfunction and also increases levels of endogenous antioxidants, including Mn-SOD, Cu/Zn-SOD, and glutathione.

Keep in mind that mouse and cell studies don’t always pan out when it comes to Alzheimer’s research… but for luteolin, there is little risk and a lot of potential benefits.

Luteolin as an anti-inflammatory:

Research also shows that luteolin may help with chronic inflammation.

  • In cell studies, luteolin inhibits TNF-alpha and IL-6 released via suppressing NF-κB.[ref] TNF-alpha and IL-6 are linked to many chronic diseases caused by elevated inflammatory cytokines. 
  • In other research, luteolin reduces IL-6 (interleukin 6), an inflammatory cytokine produced in response to bacterial infections.[ref]
  • In microglial cells, luteolin and another flavonoid, apigenin, suppress IL-31 and IL-33.[ref] IL-31 is an inflammatory cytokine produced by activated T lymphocytes, and it plays a role in chronic inflammatory diseases.

All in all, the research shows luteolin as a specific anti-inflammatory to target elevated TNF, IL-6, IL-31, and IL-33.

Luteolin and sleep:

Animal studies show that luteolin has a sleep-inducing effect – at least when given with a sleep drug.

Interestingly, this hypnotic effect was driven by interactions with the adenosine receptor. The build-up of adenosine and its binding with the adenosine receptor drives us to need to sleep each night, so the interaction with the adenosine receptor theoretically would only increase sleepiness at the end of the day (not making you sleepy during the day). Additionally, the research showed that luteolin increased sleep time and non-REM sleep.[ref]

Luteolin as an antimicrobial:

Cell studies show that luteolin acts as an antimicrobial agent against several common bacterial and viral pathogens.

  • It stops the growth of Staphylococcus aureus (staph infection).[ref]
  • Luteolin acts as an antiviral agent against one of the causes of encephalitis (Flaviviridae virus).[ref]
  • In trials for SARS-CoV-1, luteolin blocks viral entry into host cells. Some researchers theorize it may also be helpful for SARS-CoV-2, but clinical trials are needed.[ref]
  • Cell studies also show that luteolin has antiviral activity against the flu virus (H1N1).[ref]

Luteolin inhibits cell proliferation in cancer:

First and foremost, let me emphasize that I am not advocating for anyone to self-treat cancer with supplements. Instead, this research summary provides broad cancer prevention advice.

In epidemiological research, eating fruits and vegetables has been linked to lower cancer risk. However, epidemiological studies that ask people what they eat and then associate that with an outcome are really just vague pointers towards a possible link. Perhaps people who naturally eat many vegetables are also likely to have genetic variants in their taste receptors. It is possible these variants could also impact cancer risk.

Multiple studies have shown that luteolin induces apoptosis (cell death) in cancer cells in vitro. It also causes cell cycle arrest, which prevents cancer cells from replicating. Studies show that luteolin inhibits cancer cell proliferation in two ways: by blocking the IGF1 receptor and by acting on GSK-3. Recent studies also show that luteolin downregulates mTOR and upregulates P53 (tumor suppressor gene).[ref][ref][ref][ref]

While it is excellent that luteolin works to stop many different types of cancer cells from proliferating in a petri dish, the question remains whether this works at obtainable levels in real life. In other words, can you take enough supplemental luteolin to actually make a difference – without side effects? It is a question that needs clinical trials for answers.

What about just eating foods rich in flavonoids? A trial looking at cancer prevention from consuming flavonoid-rich vegetables, including luteolin content, found no difference in cancer risk among women who consumed the most flavonoids compared to the least.[ref]

Luteolin for skin health and sunburns:

A clinical trial found that a nanoparticle formula containing a luteolin-rich plant extract decreased UVB-induced erythema (e.g., sunburns). The formula seemed to work when applied before UVB exposure and, to some extent, after exposure. After exposure, the luteolin-rich plant extract was as effective as the hydrocortisone cream.[ref]

Luteolin in cholesterol levels:

There is a ton of research on cholesterol, and much of it seems contradictory — what is the right amount? Instead of looking only at total cholesterol or just LDL cholesterol, researchers are now dialing in the specific types of cholesterol-related lipid particles.

In general, apoB-containing lipoproteins, such as LDL and chylomicron remnants, link to plaque buildup in the arteries (not good).[ref] Luteolin acts on HNF4α, a nuclear transcription factor, in regulating the secretion of apolipoprotein B (apo B) containing lipoproteins.[ref] This means that luteolin is acting upstream of the production of cholesterol in the liver — regulating the production of cholesterol.

Gut Microbiome:

The gut microbiome and intestinal barrier integrity are essential in preventing fatty liver disease (NAFLD).

Luteolin protects against fatty liver by improving the intestinal barrier integrity. It also increases microbial diversity in the gut, according to animal studies.[ref]

Related article: NAFLD and genetics


Absorption, Side Effects, and Metabolism of luteolin:

The rest of this article is for Genetic Lifehacks members only.  Consider joining today to see the rest of this article.

Member Content:

An active subscription is required to access this content.

Join Here for full access to this article, genotype reports, and much more!


Already a member? Log in below.


Related Articles and Topics:

COMT: Interactions with Supplements
Some supplements interact with COMT variants to impact the rate at which neurotransmitters are broken down. Check your COMT genotype and discover how this may affect your reaction to different supplements or combinations of supplements.

Spike Protein, Mast Cells, Histamine, and Heart Rhythms
Do you know of someone with unexplained heart palpitations, spiking blood pressure, dizziness, and tinnitus? Discover how research links these symptoms to histamine, mast cells, and the spike protein.

Mast cells: MCAS, genetics, and solutions
Mast cells are essential to your innate immune system, defending against pathogens and allergens. For some people, mast cells can be triggered too easily, giving allergy-like responses to many substances.

TNF-alpha: Inflammation and Your Genes
Do you feel like you are always dealing with inflammation? Joint pain, food sensitivity, etc? Perhaps you are genetically geared towards a higher inflammatory response. Tumor necrosis factor (TNF) is an inflammatory cytokine that acts as a signaling molecule in our immune system.

References:

Burton, Michael D., et al. “Dietary Luteolin Reduces Proinflammatory Microglia in the Brain of Senescent Mice.” Rejuvenation Research, vol. 19, no. 4, Aug. 2016, pp. 286–92. PubMed Central, https://doi.org/10.1089/rej.2015.1708.

Cao, Lei, et al. “Metabolic Interactions between Acetaminophen (Paracetamol) and Two Flavonoids, Luteolin and Quercetin, through in-Vitro Inhibition Studies.” The Journal of Pharmacy and Pharmacology, vol. 69, no. 12, Sept. 2017, pp. 1762–72. PubMed Central, https://doi.org/10.1111/jphp.12812.

Cárdenas-Rodríguez, Noemí, et al. “Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19.” Antioxidants (Basel, Switzerland), vol. 10, no. 6, June 2021, p. 971. PubMed, https://doi.org/10.3390/antiox10060971.

Casetti, F., et al. “Topical Application of Solubilized Reseda Luteola Extract Reduces Ultraviolet B-Induced Inflammation in Vivo.” Journal of Photochemistry and Photobiology. B, Biology, vol. 96, no. 3, Sept. 2009, pp. 260–65. PubMed, https://doi.org/10.1016/j.jphotobiol.2009.07.003.

Che, Denis Nchang, et al. “Effect of Luteolin and Apigenin on the Production of Il-31 and Il-33 in Lipopolysaccharides-Activated Microglia Cells and Their Mechanism of Action.” Nutrients, vol. 12, no. 3, Mar. 2020, p. E811. PubMed, https://doi.org/10.3390/nu12030811.

Chen, Jingshan, et al. “Functional Analysis of Genetic Variation in Catechol-O-Methyltransferase (COMT): Effects on MRNA, Protein, and Enzyme Activity in Postmortem Human Brain.” American Journal of Human Genetics, vol. 75, no. 5, Nov. 2004, pp. 807–21. PubMed, https://doi.org/10.1086/425589.

Deng, Changrui, et al. “Pharmacokinetics, Tissue Distribution and Excretion of Luteolin and Its Major Metabolites in Rats: Metabolites Predominate in Blood, Tissues and Are Mainly Excreted via Bile.” Journal of Functional Foods, vol. 35, Aug. 2017, pp. 332–40. ScienceDirect, https://doi.org/10.1016/j.jff.2017.05.056.

Fan, Wenchun, et al. “Antiviral Activity of Luteolin against Japanese Encephalitis Virus.” Virus Research, vol. 220, July 2016, pp. 112–16. PubMed, https://doi.org/10.1016/j.virusres.2016.04.021.

Ham, Sunyoung, et al. “Luteolin Induces Intrinsic Apoptosis via Inhibition of E6/E7 Oncogenes and Activation of Extrinsic and Intrinsic Signaling Pathways in HPV-18-Associated Cells.” Oncology Reports, vol. 31, no. 6, June 2014, pp. 2683–91. PubMed, https://doi.org/10.3892/or.2014.3157.

Jang, Saebyeol, et al. “Luteolin Reduces IL-6 Production in Microglia by Inhibiting JNK Phosphorylation and Activation of AP-1.” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 21, May 2008, pp. 7534–39. PubMed, https://doi.org/10.1073/pnas.0802865105.

Kempuraj, D., et al. “Luteolin Inhibits Myelin Basic Protein-Induced Human Mast Cell Activation and Mast Cell-Dependent Stimulation of Jurkat T Cells.” British Journal of Pharmacology, vol. 155, no. 7, Dec. 2008, pp. 1076–84. PubMed Central, https://doi.org/10.1038/bjp.2008.356.

Li, Juan, et al. “Identification of the Flavonoid Luteolin as a Repressor of the Transcription Factor Hepatocyte Nuclear Factor 4α.” The Journal of Biological Chemistry, vol. 290, no. 39, Sept. 2015, pp. 24021–35. PubMed Central, https://doi.org/10.1074/jbc.M115.645200.

Li, L. P., et al. “Interspecies Difference of Luteolin and Apigenin after Oral Administration of Chrysanthemum Morifolium Extract and Prediction of Human Pharmacokinetics.” Die Pharmazie, vol. 68, no. 3, Mar. 2013, pp. 195–200.

Lin, Yong, et al. “Luteolin, a Flavonoid with Potentials for Cancer Prevention and Therapy.” Current Cancer Drug Targets, vol. 8, no. 7, Nov. 2008, pp. 634–46. PubMed Central, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615542/.

Liu, Feng, et al. “The Small Molecule Luteolin Inhibits N-Acetyl-α-Galactosaminyltransferases and Reduces Mucin-Type O-Glycosylation of Amyloid Precursor Protein.” The Journal of Biological Chemistry, vol. 292, no. 52, Dec. 2017, pp. 21304–19. PubMed Central, https://doi.org/10.1074/jbc.M117.814202.

Morita, Shin-ya. “Metabolism and Modification of Apolipoprotein B-Containing Lipoproteins Involved in Dyslipidemia and Atherosclerosis.” Biological & Pharmaceutical Bulletin, vol. 39, no. 1, 2016, pp. 1–24. PubMed, https://doi.org/10.1248/bpb.b15-00716.

Qian, Weidong, et al. “Antimicrobial Mechanism of Luteolin against Staphylococcus Aureus and Listeria Monocytogenes and Its Antibiofilm Properties.” Microbial Pathogenesis, vol. 142, Feb. 2020, p. 104056. PubMed, https://doi.org/10.1016/j.micpath.2020.104056.

Raina, Ritu, et al. “Luteolin Inhibits Proliferation, Triggers Apoptosis and Modulates Akt/MTOR and MAP Kinase Pathways in HeLa Cells.” Oncology Letters, vol. 21, no. 3, Mar. 2021, p. 192. PubMed Central, https://doi.org/10.3892/ol.2021.12452.

Russo, Maria, et al. “Roles of Flavonoids against Coronavirus Infection.” Chemico-Biological Interactions, vol. 328, Sept. 2020, p. 109211. PubMed Central, https://doi.org/10.1016/j.cbi.2020.109211.

Shimoi, Kayoko, et al. “Intestinal Absorption of Luteolin and Luteolin 7-O-β-Glucoside in Rats and Humans.” FEBS Letters, vol. 438, no. 3, Nov. 1998, pp. 220–24. ScienceDirect, https://doi.org/10.1016/S0014-5793(98)01304-0.

Sun, Wen-Long, et al. “Anti-Inflammatory Effect of Luteolin Is Related to the Changes in the Gut Microbiota and Contributes to Preventing the Progression from Simple Steatosis to Nonalcoholic Steatohepatitis.” Bioorganic Chemistry, vol. 112, July 2021, p. 104966. ScienceDirect, https://doi.org/10.1016/j.bioorg.2021.104966.

Theoharides, Theoharis, et al. “Brain ‘Fog,’ Inflammation and Obesity: Key Aspects of Neuropsychiatric Disorders Improved by Luteolin.” Frontiers in Neuroscience, vol. 9, 2015. Frontiers, https://www.frontiersin.org/article/10.3389/fnins.2015.00225.

Tuorkey, Muobarak J. “Molecular Targets of Luteolin in Cancer.” European Journal of Cancer Prevention, vol. 25, no. 1, Jan. 2016, pp. 65–76. PubMed Central, https://doi.org/10.1097/CEJ.0000000000000128.

Wang, Liang-Jen, et al. “A Potential Interaction between COMT and MTHFR Genetic Variants in Han Chinese Patients with Bipolar II Disorder.” Scientific Reports, vol. 5, Mar. 2015, p. 8813. PubMed Central, https://doi.org/10.1038/srep08813.

Wang, Lu, et al. “Dietary Intake of Selected Flavonols, Flavones, and Flavonoid-Rich Foods and Risk of Cancer in Middle-Aged and Older Women.” The American Journal of Clinical Nutrition, vol. 89, no. 3, Mar. 2009, pp. 905–12. PubMed, https://doi.org/10.3945/ajcn.2008.26913.

Wu, Guixia, et al. “Liposome Encapsulated Luteolin Showed Enhanced Antitumor Efficacy to Colorectal Carcinoma.” Molecular Medicine Reports, vol. 17, no. 2, Feb. 2018, pp. 2456–64. PubMed Central, https://doi.org/10.3892/mmr.2017.8185.

Yan, Haiyan, et al. “Luteolin Decreases the Yield of Influenza A Virus in Vitro by Interfering with the Coat Protein I Complex Expression.” Journal of Natural Medicines, vol. 73, no. 3, June 2019, pp. 487–96. PubMed, https://doi.org/10.1007/s11418-019-01287-7.

Yao, Zhao-Hui, et al. “Luteolin Could Improve Cognitive Dysfunction by Inhibiting Neuroinflammation.” Neurochemical Research, vol. 43, no. 4, Apr. 2018, pp. 806–20. PubMed, https://doi.org/10.1007/s11064-018-2482-2.

Ying, Jing-Yan, et al. “[Research progress on interactions between luteolin (glucosides) and drug-metabolizing enzyme].” Yao Xue Xue Bao = Acta Pharmaceutica Sinica, vol. 43, no. 4, Apr. 2008, pp. 335–42.


About the Author:
Debbie Moon is the founder of Genetic Lifehacks. Fascinated by the connections between genes, diet, and health, her goal is to help you understand how to apply genetics to your diet and lifestyle decisions. Debbie has a BS in engineering and also an MSc in biological sciences from Clemson University. Debbie combines an engineering mindset with a biological systems approach to help you understand how genetic differences impact your optimal health.